Nxera Pharma Co (Nxera Pharma Co) Price-to-Operating-Cash-Flow

: (As of Today)

View and export this data going back to . Start your Free Trial

As of today (2024-04-18), Nxera Pharma Co's share price is $9.72. Nxera Pharma Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.45. Hence, Nxera Pharma Co's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Nxera Pharma Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Nxera Pharma Co's highest Price-to-Operating-Cash-Flow Ratio was 1168.60. The lowest was 10.61. And the median was 45.92.

SOLTF's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.36
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Nxera Pharma Co's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $-0.07. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.45.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Nxera Pharma Co was -153.00% per year.

During the past 13 years, Nxera Pharma Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 211.50% per year. The lowest was -32.30% per year. And the median was 46.05% per year.

Nxera Pharma Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Nxera Pharma Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

48.89

30.65

22.16

17.74

Nxera Pharma Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow																17.74	18.36	12.42	259.07	-

Competitive Comparison

For the Biotechnology subindustry, Nxera Pharma Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nxera Pharma Co Price-to-Operating-Cash-Flow Distribution

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's Price-to-Operating-Cash-Flow falls into.

Nxera Pharma Co Price-to-Operating-Cash-Flow Calculation

Nxera Pharma Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	9.72	/	-0.452
	=

Nxera Pharma Co's Share Price of today is $9.72.
Nxera Pharma Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.45.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Nxera Pharma Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co (Nxera Pharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

4565:Japan JSS:Germany

Address

2-1 Kojimachi, Chiyoda-ku, PMO Hanzomon 11th Floor, Tokyo, JPN, 102-0083

Website

http://www.sosei.com

Sosei Group Corp is an international biopharmaceutical company that develops treatments for a wide range of illnesses. The company utilizes its peptide platform technologies and nanotechnology to develop its product pipeline. Sosei actively seeks partnerships to aid its product development. The company's strategy for commercializing its therapies include utilizing its subsidiaries' drug discovery technologies, supplying technology to other companies, developing products in-house, and product licensing.